Metal-Polymer Nanoconjugates Application in Cancer Imaging and Therapy

Area of Science:

• Nanotechnology
• Materials Science
• Biomedical Engineering

Background:

• Metallic nanoparticles possess unique physicochemical properties for applications in electronics, diagnostics, and therapeutics.
• Metallic nanoparticles are promising for cancer theranostics due to plasmonic resonance, magnetic behavior, X-ray attenuation, and radical oxygen species generation.
• Challenges with metallic nanoparticles include toxicity, poor colloidal stability, and off-target interactions.

Purpose of the Study:

• To review the application of metallic-polymer nanoconjugates/nanohybrids in cancer therapy.
• To focus on physicochemical properties enabling metallic nanomaterials for imaging and therapeutic applications.
• To provide an overview of metal-polymer conjugation advantages and common structural arrangements.

Main Methods:

• Literature review of metallic-polymer nanoconjugates for cancer therapy.
• Analysis of physicochemical properties of metallic nanomaterials.
• Discussion of metal-polymer conjugation strategies and structural arrangements.
• Examination of applications using gold, iron, and copper-based nanoconjugates.

Main Results:

• Metal-polymer conjugation enhances biocompatibility, colloidal stability, and tumor specificity.
• Metallic-polymer nanoconjugates serve as multifunctional platforms for cancer theranostics.
• Various metallic elements (gold, iron, copper) are utilized in these nanoconjugates for cancer treatment.

Conclusions:

• Metallic-polymer nanoconjugates represent a promising all-in-one solution for cancer therapy.
• Further research and clinical trials are needed to fully realize the potential of these advanced nanomedicines.